IMFINZI
Live / Registered — Registered — international registration renewed (as of 02 Oct 2024)
What this means for you
Registered since 12 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79218364
- Registration number
- 5488935
- Mark type
- Design + words
- Filed
- 24 Aug 2017
- Published for opposition
- 27 Mar 2018
- Registered
- 12 Jun 2018
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prior registrations
Prosecution history
- 02 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 02 Oct 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 23 Sept 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Jan 2024 — TEAS SECTION 71 & 15 RECEIVED
- 12 Jun 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 12 Oct 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Sept 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Sept 2018 — FINAL DISPOSITION PROCESSED
- 12 Sept 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 12 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 27 Mar 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Mar 2018 — PUBLISHED FOR OPPOSITION
- 07 Mar 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Feb 2018 — ASSIGNED TO LIE
- 13 Feb 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER